We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$524M
Cap. Flow %
386.8%
Top 10 Hldgs %
40.45%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$13M
2
CMG icon
Chipotle Mexican Grill
CMG
+$8.2M
3
CELG
Celgene Corp
CELG
+$6.34M
4
CMRX
Chimerix, Inc.
CMRX
+$5.55M
5
DYAX
DYAX CORPORATION
DYAX
+$5.42M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 43.09%
2 Consumer Discretionary 6.1%
3 Materials 3.81%
4 Consumer Staples 3.68%
5 Technology 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
201
CALL
ImmunityBio
IBRX
$7.8B
$1K ﹤0.01%
+2,000
New +$29.7K
MDLZ icon
202
PUT
Mondelez International
MDLZ
$78.8B
$1K ﹤0.01%
+5,000
New +$224K
MNKD icon
203
CALL
MannKind Corp
MNKD
$1.25B
$1K ﹤0.01%
+26,900
New +$331K
SRPT icon
204
PUT
Sarepta Therapeutics
SRPT
$1.82B
$1K ﹤0.01%
+65,400
New +$2.12M
5 6 7 8
9

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for FT Options, which disclosed 204 positions worth $136M. Its ten largest holdings account for 40% of the portfolio.

Its largest position is Gilead Sciences: 125,233 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Materials.

  • FT Options's largest Q4 2015 buy was Gilead Sciences: 125,233 shares worth $12.7M.
  • FT Options's ten largest holdings make up 40% of its $136M portfolio in Q4 2015.
  • FT Options disclosed 204 positions in Q4 2015, its first 13F filing on record.

Based on FT Options's 13F filing for Q4 2015, filed 5 Feb 2016.